Diaphragm-Pelvic Floor Synergy Training in Young Females With Primary Dysmenorrhea.
Effects of Diaphragm-Pelvic Floor Synergy Training on Pain and Quality of Life in Young Females With Primary Dysmenorrhea.
1 other identifier
interventional
64
1 country
1
Brief Summary
The research investigating the effects of Diaphragm-Pelvic Floor Synergy (DPFS) training targets primary dysmenorrhea in university-aged females. This randomized controlled trial evaluates how restoring the functional "piston" relationship between the diaphragm and pelvic floor can alleviate menstrual pain and enhance quality of life. By implementing an eight-week progressive exercise protocol, the study compares DPFS training against standard symptomatic care like TENS and heat therapy. Using the WALIDD scale and WHOQOL-BREF, the research aims to establish a non-pharmacological, evidence-based physiotherapy intervention that reduces medication reliance and academic absenteeism in South Asian clinical settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 28, 2026
CompletedFirst Submitted
Initial submission to the registry
August 5, 2026
CompletedFirst Posted
Study publicly available on registry
August 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
August 10, 2026
August 1, 2026
3 months
August 5, 2026
August 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Working Ability, Location, Intensity, Days of pain, and Dysmenorrhea (WALIDD) Scale
The WALIDD scale is a validated multi-dimensional tool used to assess the severity of primary dysmenorrhea. It evaluates five specific areas: work interference, anatomical location of pain, pain intensity, duration of symptoms, and the clinical grade of dysmenorrhea. Scores range from 0 to 12, where 1-4 indicates mild, 5-7 moderate, and 8-12 severe pain.
Baseline (Pre-intervention), 8 weeks (Immediate post-intervention), and 3 months (Follow-up).
Secondary Outcomes (1)
: World Health Organization Quality of Life-BREF (WHOQOL-BREF)
Baseline (Pre-intervention), 8 weeks (Immediate post-intervention), and 3 months (Follow-up).
Study Arms (2)
Diaphragm-Pelvic Floor Synergy (DPFS) Training
EXPERIMENTALParticipants in this group undergo an active neuromuscular re-education protocol. The intervention focuses on restoring the "piston-like" coordination between the thoracic diaphragm and the pelvic floor muscles. Over an 8-week period, participants perform supervised exercises three times per week that synchronize breathing with pelvic floor activation. The training is progressive, advancing through four postural stages (supine, sitting, quadruped, and standing) to challenge the core's ability to regulate intra-abdominal pressure and alleviate symptoms of primary dysmenorrhea.
Standard Symptomatic Care
ACTIVE COMPARATORThis group serves as the clinical control, receiving conventional physiotherapy typically used for menstrual pain relief. During the first three days of the menstrual cycle, participants receive passive modalities, including High-Frequency Transcutaneous Electrical Nerve Stimulation (TENS) and moist heat therapy. On non-menstrual days, the group performs supervised Progressive Muscle Relaxation (PMR) three times per week. This design ensures that the control group remains as active as the experimental group while receiving standard-of-care treatments for symptom management.
Interventions
This intervention is a supervised 8-week program consisting of 3 sessions per week. It focuses on the functional coordination of the thoracic diaphragm and pelvic floor muscles to regulate intra-abdominal pressure. The protocol involves a "piston" technique where participants perform a 4-second slow inhalation (allowing the pelvic floor to relax and descend) followed by a 6-second pursed-lip exhalation (actively contracting and elevating the pelvic floor). The training is progressive, advancing every two weeks through four postural levels: supine, sitting, quadruped, and standing.
This arm receives established clinical treatments for menstrual pain. During the first three days of the menstrual cycle, participants receive 30 minutes of High-Frequency Transcutaneous Electrical Nerve Stimulation (TENS) at 100 Hz and 20 minutes of moist heat therapy. On non-menstrual days, they participate in supervised Progressive Muscle Relaxation (PMR) sessions three times per week to manage general muscle tension and stress.
Eligibility Criteria
You may qualify if:
- University going girls aged 18-24 years.
- Normal weight (BMI 18.5-24.9 kg/m²) based on measured height and weight.
- Primary dysmenorrhea: recurrent menstrual pain without pelvic pathology, present for ≥6 months, with pain intensity ≥4/10 on VAS.
- Regular menstrual cycles (21-35 days).
- From socioeconomically disadvantaged backgrounds (e.g., low parental education, low household income, government/public school enrolment - specify in protocol).
- Currently enrolled in school/college.
- Informed consent/assent obtained (with parental consent if \<18 years).
- Willing to participate in intervention and data collection.
You may not qualify if:
- diagnosed pelvic pathologies (e.g., endometriosis, fibroids, pelvic inflammatory disease).
- Irregular menstrual cycles (\<21 days or \>35 days).
- Current or recent use of hormonal contraceptives or hormonal therapy (within last 3 months).
- History of pelvic/abdominal surgery.
- Pregnancy or recent childbirth (within 6 months).
- Any diagnosed musculoskeletal, neurological, or medical condition contraindicating exercise or acupressure.
- Current participation in another clinical trial or structured exercise/physiotherapy program for dysmenorrhea.
- Unwillingness to provide consent/assent or comply with study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prime Institute of Health Sciences, Islamabad
Islamabad, Punjab Province, 44000, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Summra Andleeb, MSOMPT
Riphah International University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2026
First Posted
August 10, 2026
Study Start
July 28, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
August 10, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share